The TACIT Trial: TAi ChI for People With demenTia

NCT02864056 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 172

Last updated 2018-12-17

No results posted yet for this study

Summary

This is a three-centre parallel group randomised controlled trial with an embedded process evaluation and intervention pilot phase (details not provided in this summary). The overall research question is: Can a Tai Chi exercise programme prevent falls among people with dementia (PWD), specifically among older PWD living at home?

Primary Outcome measure:

• dynamic postural balance (as a surrogate for falls).

Secondary outcome measures:

* to explore the effects of a Tai Chi exercise programme on static and functional postural balance, fear of falling, cognitive functioning, falls, and quality of life. Also to explore the effects of a Tai Chi exercise programme on their informal carer's dynamic and static postural balance, quality of life, and carer burden
* to determine the acceptability and safety of the Tai Chi intervention
* to inform the design of a future definitive clinical trial.

Conditions

Interventions

OTHER

Tai Chi

Ancient Chinese form of mind/body gentle exercise; this will be done while standing to improve postural balance.

Sponsors & Collaborators

  • Southern Health NHS Foundation Trust

    collaborator OTHER
  • Dorset HealthCare University NHS Foundation Trust

    collaborator OTHER
  • University of Plymouth

    collaborator OTHER
  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV
  • University of Southampton

    collaborator OTHER
  • Elemental Tai Chi

    collaborator UNKNOWN
  • Alzheimer's Society

    collaborator OTHER
  • Solent NHS Trust

    collaborator OTHER_GOV
  • Bournemouth University

    lead OTHER

Principal Investigators

  • Samuel Nyman, PhD · Bournemouth University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-06
Primary Completion
2018-12-01
Completion
2018-12-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02864056 on ClinicalTrials.gov